339 related articles for article (PubMed ID: 15862619)
1. The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy.
Aparicio AM; Elkhouiery AB; Quinn DI
Urol Clin North Am; 2005 May; 32(2):217-30, vii. PubMed ID: 15862619
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant and neoadjuvant chemotherapy for urothelial carcinoma.
McCaffrey JA; Herr HW
Surg Oncol Clin N Am; 1997 Oct; 6(4):667-81. PubMed ID: 9309087
[TBL] [Abstract][Full Text] [Related]
4. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
Sternberg CN
Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
[TBL] [Abstract][Full Text] [Related]
6. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
Lehmann J; Franzaring L; Thüroff J; Wellek S; Stöckle M
BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
[TBL] [Abstract][Full Text] [Related]
7. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy.
Lehmann J; Retz M; Stöckle M
World J Urol; 2002 Aug; 20(3):144-50. PubMed ID: 12196897
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for bladder cancer. Standard of care or unproven therapy?
Bahnson RR; Smith D; Trump D
Surg Oncol Clin N Am; 1995 Apr; 4(2):287. PubMed ID: 7796287
[TBL] [Abstract][Full Text] [Related]
10. Systemic chemotherapy in regionally advanced bladder cancer. Theoretical considerations and results.
Scher HI
Urol Clin North Am; 1992 Nov; 19(4):747-59. PubMed ID: 1441029
[TBL] [Abstract][Full Text] [Related]
11. The role of chemotherapy in the management of the patient with T3b bladder cancer.
Millikan R; Dinney CP
Semin Urol Oncol; 1996 May; 14(2):81-5. PubMed ID: 8734735
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
Calabrò F; Sternberg CN
Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
[TBL] [Abstract][Full Text] [Related]
13. Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer.
Porter MP; Kerrigan MC; Donato BM; Ramsey SD
Urol Oncol; 2011; 29(3):252-8. PubMed ID: 19450992
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy following cystectomy benefits patients with deeply invasive bladder cancer.
Skinner DG; Daniels JR; Russell CA; Lieskovsky G; Boyd SD; Krailo M; Groshen S
Semin Urol; 1990 Nov; 8(4):279-84. PubMed ID: 2284533
[No Abstract] [Full Text] [Related]
16. [Chemotherapy for urothelial cancer of the bladder--update 2012].
Niegisch G; Lorch A; Albers P
Aktuelle Urol; 2012 Dec; 43(6):412-9. PubMed ID: 23196781
[TBL] [Abstract][Full Text] [Related]
17. Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy.
Suttmann H; Kamradt J; Lehmann J; Stöckle M
BJU Int; 2007 Dec; 100(6):1225-8. PubMed ID: 17979921
[TBL] [Abstract][Full Text] [Related]
18. Current status of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
Rosenberg JE
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1729-36. PubMed ID: 18062747
[TBL] [Abstract][Full Text] [Related]
19. [Treatments for advanced transitional cell carcinoma of the urinary tract: chemotherapy and operation].
Ozono S; Takashima K; Tabata S; Hirao Y; Okajima E
Hinyokika Kiyo; 1994 Oct; 40(10):931-8. PubMed ID: 7992711
[TBL] [Abstract][Full Text] [Related]
20. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.
Izawa JI; Chin JL; Winquist E
Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]